The deal will give CSL the exclusive licence to US company Arcturus Therapeutics’ technology in the fields of influenza, COVID-19 and other respiratory diseases.
Business / Companies
Brisbane Times – Business
The deal will give CSL the exclusive licence to US company Arcturus Therapeutics’ technology in the fields of influenza, COVID-19 and other respiratory diseases.
Business / Companies
Brisbane Times – Business